Literature DB >> 19434554

Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.

G F Koob1.   

Abstract

Drug addiction is conceptualized as chronic, relapsing compulsive use of drugs with significant dysregulation of brain hedonic systems. Compulsive drug use is accompanied by decreased function of brain substrates for drug positive reinforcement and recruitment of brain substrates mediating the negative reinforcement of motivational withdrawal. The neural substrates for motivational withdrawal ("dark side" of addiction) involve recruitment of elements of the extended amygdala and the brain stress systems, including corticotropin-releasing factor and norepinephrine. These changes, combined with decreased reward function, are hypothesized to persist in the form of an allostatic state that forms a powerful motivational background for relapse. Relapse also involves a key role for the basolateral amygdala in mediating the motivational effects of stimuli previously paired with drug seeking and drug motivational withdrawal. The basolateral amygdala has a key role in mediating emotional memories in general. The hypothesis argued here is that brain stress systems activated by the motivational consequences of drug withdrawal can not only form the basis for negative reinforcement that drives drug seeking, but also potentiate associative mechanisms that perpetuate the emotional state and help drive the allostatic state of addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434554      PMCID: PMC2739305          DOI: 10.1055/s-0029-1216356

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  81 in total

Review 1.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 2.  Anatomical "circuitry" in the brain mediating alcohol drinking revealed by THP-reactive sites in the limbic system.

Authors:  R D Myers
Journal:  Alcohol       Date:  1990 Sep-Oct       Impact factor: 2.405

3.  Spino (trigemino) parabrachiohypothalamic pathway: electrophysiological evidence for an involvement in pain processes.

Authors:  H Bester; L Menendez; J M Besson; J F Bernard
Journal:  J Neurophysiol       Date:  1995-02       Impact factor: 2.714

4.  CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

Authors:  H A Baldwin; S Rassnick; J Rivier; G F Koob; K T Britton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Animal models of drug craving.

Authors:  A Markou; F Weiss; L H Gold; S B Caine; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

7.  The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat.

Authors:  S Rassnick; L Stinus; G F Koob
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

8.  Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration.

Authors:  F Weiss; A Markou; M T Lorang; G F Koob
Journal:  Brain Res       Date:  1992-10-16       Impact factor: 3.252

9.  Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.

Authors:  J E LeDoux; J Iwata; P Cicchetti; D J Reis
Journal:  J Neurosci       Date:  1988-07       Impact factor: 6.167

10.  Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures.

Authors:  H C Becker
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

View more
  88 in total

1.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

2.  A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.

Authors:  H Shen; A Mohammad; J Ramroop; S S Smith
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

3.  Serotonin 1B receptor imaging in alcohol dependence.

Authors:  Jian Hu; Shannan Henry; Jean-Dominique Gallezot; Jim Ropchan; John F Neumaier; Marc N Potenza; Rajita Sinha; John H Krystal; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Alexander Neumeister
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

4.  The endocannabinoid system modulates the valence of the emotion associated to food ingestion.

Authors:  Mónica Méndez-Díaz; Pavel Ernesto Rueda-Orozco; Alejandra Evelyn Ruiz-Contreras; Oscar Prospéro-García
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

5.  Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients.

Authors:  Jung Hye Kwon; Kimberson Tanco; Ji Chan Park; Angelique Wong; Lisa Seo; Diane Liu; Gary Chisholm; Janet Williams; David Hui; Eduardo Bruera
Journal:  Oncologist       Date:  2015-05-01

6.  CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.

Authors:  Kiri L Wills; Kiran Vemuri; Alana Kalmar; Alan Lee; Cheryl L Limebeer; Alexandros Makriyannis; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2014-04-27       Impact factor: 4.530

7.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

Review 8.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

Review 9.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

10.  The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.

Authors:  Jessica L Kissler; Sunil Sirohi; Daniel J Reis; Heiko T Jansen; Raymond M Quock; Daniel G Smith; Brendan M Walker
Journal:  Biol Psychiatry       Date:  2013-04-21       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.